申请人:Oncostellae, S.L.
公开号:EP3480201A1
公开(公告)日:2019-05-08
The present invention relates to novel dihydropyridine derivatives of formula (I):
as modulators of nuclear receptors selected from androgen receptor and glucocorticoid receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by modulation of androgen receptor and/or glucocorticoid receptor, selected from cancer, metastasizing cancers, benign prostate hyperplasia, polycystic ovary syndrome (PCOS), hair loss, hirsutism, acne, hypogonadism, muscle wasting diseases, cachexia, Cushing's syndrome, anti-psychotic drug induced weight gain, obesity, post-traumatic stress disorder and alcoholism.
本发明涉及一种新型的二氢吡啶衍生物,其化学式为(I):作为选择的核受体调节剂,所述核受体包括雄激素受体和糖皮质激素受体,以及其制备方法,包括所述化合物的制药组合物和利用所述化合物制造用于治疗可以通过调节雄激素受体和/或糖皮质激素受体改善的病理情况或疾病的药物,所述病理情况或疾病包括癌症、转移性癌症、良性前列腺增生、多囊卵巢综合征(PCOS)、脱发、多毛症、痤疮、性腺功能减退、肌肉消耗性疾病、虚弱、库欣综合征、抗精神病药物诱导的体重增加、肥胖、创伤后应激障碍和酗酒。